Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for breast cancer and other aggressive cancers. Leveraging unique approaches like selective estrogen receptor modulators (SERMs) and intraductal technology, Atossa aims to address unmet needs in cancer treatment and prevention. Committed to precision oncology, Atossa’s mission is to create effective, targeted therapies that improve patient outcomes and offer new hope for cancer patients worldwide.